AR and metastatic prostate carcinoma: In this Surveillance, Epidemiology, and End Results‐Medicare based study of older adults with metastatic prostate cancer, both polypharmacy and nonadherence to androgen receptor signaling inhibitors were common and independently associated with increased acute care use.